180 Wealth Advisors »

SPDR S&P Biotech shares owned by 180 Wealth Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by 180 Wealth Advisors from 13F filings

Historical chart of 180 Wealth Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by 180 Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by 180 Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $375k 4.0k 94.89
2023-12-31 $250k 2.8k 90.23

More positions owned by 180 Wealth Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
Mannkind Corp Com New (MNKD)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Whitehall Fds High Div Yld (VYM)
Meta Platforms Cl A (META)
Costco Wholesale Corporation (COST)
Tesla Motors (TSLA)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
Alphabet Cap Stk Cl C (GOOG)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Us Vlu (IUSV)

View all positions for 180 Wealth Advisors

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities

View all funds holding SPDR S&P Biotech